Skip to main content

HTR2B

  • Reference work entry
  • First Online:
  • 218 Accesses

Synonyms

5-Hydroxytryptamine (serotonin) receptor 2B; 5-HT 2B receptor; 5-HT(2B); 5-HT-2B; 5-HT2B; Serotonin receptor 2B; 5-Hydroxytryptamine 2B receptor

Historical Background

Because of its exquisite sensitivity to serotonin, the rat stomach fundus was used as a bioassay for serotonin before the development of more quantitative analytical assays for this biogenic amine (Vane 1957). Although the potency for the contractile effects of serotonin has been known for long time, the receptors mediating such a response have eluded definitive characterization for long time. Pharmacological studies attempting to characterize the contractile serotonergic receptor in the rat stomach fundus documented the similarity to the 5-HT2C receptor. In the absence of detectable 5-HT2C receptor mRNA in the rat stomach fundus, only molecular cloning allowed the identification of a new receptor in 1992 in rat and mouse (Foguet et al. 1992; Kursar et al. 1992; Loric et al. 1992; Wainscott et al. 1993) and in...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aira Z, Buesa I, Salgueiro M, Bilbao J, Aguilera L, Zimmermann M, Azkue JJ. Subtype-specific changes in 5-HT receptor-mediated modulation of C fibre-evoked spinal field potentials are triggered by peripheral nerve injury. Neuroscience. 2010;168(3):831–41.

    Article  PubMed  CAS  Google Scholar 

  • Aira Z, Buesa I, García Del Caño G, Salgueiro M, Mendiable N, Mingo J, Azkue JJ. Selective impairment of spinal mu-opioid receptor mechanism by plasticity of serotonergic facilitation mediated by 5-HT2A and 5-HT2B receptors. Pain. 2012;153(7):1418–25.

    Article  PubMed  CAS  Google Scholar 

  • Aira Z, Buesa I, García Del Caño G, Bilbao J, Doñate F, Zimmermann M, Azkue JJ. Transient, 5-HT2B receptor-mediated facilitation in neuropathic pain: up-regulation of PKCγ and engagement of the NMDA receptor in dorsal horn neurons. Pain. 2013;154(9):1865–77.

    Article  PubMed  CAS  Google Scholar 

  • Aira Z, Buesa I, Rada D, Gómez-Esteban JC, Azkue JJ. Coupling of serotonergic input to NMDA receptor-phosphorylation following peripheral nerve injury via rapid, synaptic up-regulation of ND2. Exp Neurol. 2014;255C:86–95.

    Article  CAS  Google Scholar 

  • Antonini A, Poewe W. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson’s disease. Lancet Neurol. 2007;6(9):826–9.

    Article  PubMed  CAS  Google Scholar 

  • Asada M, Ebihara S, Yamanda S, Niu K, Okazaki T, Sora I, Arai H. Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation. Neoplasia. 2009;11(4):408–17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Auclair AL, Cathala A, Sarrazin F, Depoortère R, Piazza PV, Newman-Tancredi A, Spampinato U. The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity. J Neurochem. 2010;114(5):1323–32.

    PubMed  CAS  Google Scholar 

  • Audia JE, Evrard DA, Murdoch GR, Droste JJ, Nissen JS, Schenck KW, Cohen ML. Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5-HT2B) contractile receptor in the rat stomach fundus. J Med Chem. 1996;39:2773–80.

    Article  PubMed  CAS  Google Scholar 

  • Ayme-Dietrich E, Lawson R, Gasser B, Dallemand R, Bischoff N, Monassier L. Mitral bioprosthesis hypertrophic scaring and native aortic valve fibrosis during benfluorex therapy. Fundam Clin Pharmacol. 2012;26(2):215–8.

    Article  PubMed  CAS  Google Scholar 

  • Bai C-F, Liu J-C, Zhao R, Cao W, Liu S-B, Zhang X-N, Zhao M-G. Role of 5-HT2B receptor in cardiomyocyte apoptosis of norepinephrine-induced cardiomyopathy model in rats. Clin Exp Pharmacol Physiol. 2010;37:e145–51.

    Article  PubMed  CAS  Google Scholar 

  • Banas S, Doly S, Boutourlinsky K, Diaz S, Belmer A, Callebert J, Maroteaux L. Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects. Neuropsychopharmacology. 2011;36:423–33.

    Article  PubMed  CAS  Google Scholar 

  • Baudry A, Bitard J, Mouillet-Richard S, Locker M, Poliard A, Launay J-M, Kellermann O. The serotonergic 5-HT2B receptor controls tissue non-specific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase C. J Biol Chem. 2010;285(34):26066–73.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Becamel C, Figge A, Poliak S, Dumuis A, Peles E, Bockaert J, Ullmer C. Interaction of serotonin 5-HT2C receptors with PDZ10 of the multi PDZ protein MUPP1. J Biol Chem. 2001;276(16):12974–82.

    Article  PubMed  CAS  Google Scholar 

  • Belmer A, Doly S, Setola V, Banas SM, Moutkine I, Boutourlinsky K, Maroteaux L. Role of the N-terminal region in G-Protein coupled receptor functions: negative modulation revealed by 5-HT2B receptor polymorphisms. Mol Pharmacol. 2014;85(1):127–38.

    Article  PubMed  CAS  Google Scholar 

  • Bevilacqua L, Doly S, Kaprio J, Yuan Q, Tikkanen R, Paunio T, Goldman D. A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature. 2010;468(8):1061–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bhasin N, Kernick E, Luo X, Seidel HE, Weiss ER, Lauder JM. Differential regulation of chondrogenic differentiation by the serotonin2B receptor and retinoic acid in the embryonic mouse hindlimb. Dev Dyn. 2004;230(2):201–9.

    Article  PubMed  CAS  Google Scholar 

  • Bliziotes MM, Eshleman AJ, Zhang XW, Wiren KM. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone. 2001;29(5):477–86.

    Article  PubMed  CAS  Google Scholar 

  • Bonaventure P, Guo H, Tian B, Liu X, Bittner A, Roland B, Erlander MG. Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res. 2002;943(1):38–47.

    Article  PubMed  CAS  Google Scholar 

  • Bonhaus DW, Bach C, DeSouza A, Salazar FHR, Matsuoka BD, Zuppan P, Eglen RM. The pharmacology and distribution of human 5-hydroxytryptamine 2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol. 1995;115:622–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bonhaus DW, Flippin LA, Greenhouse RJ, Jaime S, Rocha C, Dawson M, Martin GR. RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. Br J Pharmacol. 1999;127(5):1075–82.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bulenger S, Marullo S, Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci. 2005;26(3):131–7.

    Article  PubMed  CAS  Google Scholar 

  • Cervantes-Durán C, Vidal-Cantú GC, Barragán-Iglesias P, Pineda-Farias JB, Bravo-Hernández M, Murbartián J, Granados-Soto V. Role of peripheral and spinal 5-HT(2B) receptors in formalin-induced nociception. Pharmacol Biochem Behav. 2012;102(1):30–5.

    Article  PubMed  CAS  Google Scholar 

  • Chabbi-Achengli Y, Launay J-M, Maroteaux L, De Vernejoul MC, Collet C. Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/δ in osteoblasts. PLoS One. 2013;8(9):e75783.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chan SY, Loscalzo J. Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol. 2008;44(1):14–30.

    Article  PubMed  CAS  Google Scholar 

  • Choi D-S, Maroteaux L. Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain. FEBS Lett. 1996;391:45–51.

    Article  PubMed  CAS  Google Scholar 

  • Choi D-S, Birraux G, Launay J-M, Maroteaux L. The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors. FEBS L. 1994;352:393–9.

    Article  CAS  Google Scholar 

  • Choi D-S, Ward S, Messaddeq N, Launay J-M, Maroteaux L. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development. 1997;124:1745–55.

    PubMed  CAS  Google Scholar 

  • Cohen ML, Schenck KW, Mabry TE, Nelson DL, JE A. LY272015, a potent, selective and orally active 5-HT2B receptor antagonist. J Serv Res. 1996;3:131–44.

    CAS  Google Scholar 

  • Collet C, Schiltz C, Geoffroy V, Maroteaux L, Launay J-M, de Vernejoul M-C. The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation. FASEB J. 2008;22(2):418–27.

    Article  PubMed  CAS  Google Scholar 

  • Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337(9):581–8.

    Article  PubMed  CAS  Google Scholar 

  • Corominas R, Sobrido MJ, Ribasés M, Cuenca-León E, Blanco-Arias P, Narberhaus B, Cormand B. Association study of the serotoninergic system in migraine in the Spanish population. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):177–84.

    PubMed  CAS  Google Scholar 

  • Cremer SE, Moesgaard SG, Rasmussen CE, Zois NE, Falk T, Reimann MJ, et al. Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease. Res Vet Sci. 2015a;100:197–206.

    Article  PubMed  CAS  Google Scholar 

  • Cremer SE, Zois NE, Moesgaard SG, Ravn N, Cirera S, Honge JL, Olsen LH. Serotonin markers show altered transcription levels in an experimental pig model of mitral regurgitation. Vet J. 2015b;203(2):192–8.

    Article  PubMed  CAS  Google Scholar 

  • Cussac D, Newman-Tancredi A, Quentric Y, Carpentier N, Poissonnet G, Parmentier JG, Millan MJ. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols. Naunyn Schmiedeberg's Arch Pharmacol. 2002;365(3):242–52.

    Article  CAS  Google Scholar 

  • Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells. Eur J Pharmacol. 2008;594(1–3):32–8.

    Article  PubMed  CAS  Google Scholar 

  • Dawson P, Opacka-Juffry J, Moffatt JD, Daniju Y, Dutta N, Ramsey J, Davidson C. The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;48:57–63.

    Article  CAS  Google Scholar 

  • Dees C, Akhmetshina A, Reich N, Jüngel A, Beyer C, Krönke G, Distler JHW. Platelet derived serotonin links vascular disease and tissue fibrosis. J Exp Med. 2011;208(5):961–72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Diaz SL, Doly S, Narboux-Nême N, Fernandez S, Mazot P, Banas S, Maroteaux L. 5-HT2B receptors are required for serotonin-selective antidepressant actions. Mol Psychiatry. 2012;17:154–63.

    Article  PubMed  CAS  Google Scholar 

  • Diaz SL, Narboux-Nême N, Boutourlinsky K, Doly S, Maroteaux L. Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants. Eur Neuropsychopharmacol. 2016;26(2):265–79.

    Article  PubMed  CAS  Google Scholar 

  • Dizeyi N, Bjartell A, Hedlund P, Tasken KA, Gadaleanu V, Abrahamsson PA. Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines. Eur Urol. 2005;47(6):895–900.

    Article  PubMed  CAS  Google Scholar 

  • Doly S, Valjent E, Setola V, Callebert J, Herve D, Launay JM, Maroteaux L. Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. J Neurosci. 2008;28(11):2933–40.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Doly S, Bertran-Gonzalez J, Callebert J, Bruneau A, Banas SM, Belmer A, Maroteaux L. Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice. PLoS One. 2009;4(11):e7952.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dumitrascu R, Kulcke C, Königshoff M, Kouri F, Yang X, Morrell N, Pullamsetti SS. Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats. Eur Respir J. 2011;37(5):1104–18.

    Article  PubMed  CAS  Google Scholar 

  • Ebrahimkhani M, Oakley F, Murphy L, Mann J, Moles A, Perugorria M, Mann D. Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease. Nat Med. 2011;17(12):1668–73.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ellis ES, Byrne C, Murphy OE, Tilford NS, Baxter GS. Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmacol. 1995;114(2):400–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fabre A, Marchal-Sommé J, Marchand-Adam S, Quesnel C, Borie R, Dehoux M, Crestani B. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. Eur Respir J. 2008;32(2):426–36.

    Article  PubMed  CAS  Google Scholar 

  • Fatima S, Shi X, Lin Z, Chen G-q, Pan X-h, Wu JC-Y, Bian ZX. 5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin. Mol Oncol. 2016;10(2):195–212.

    Article  PubMed  CAS  Google Scholar 

  • Fernandez-Ranvier GG, Weng J, Yeh RF, Khanafshar E, Suh I, Barker C, Kebebew E. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch Surg. 2008;143(9):841–6.

    Article  PubMed  Google Scholar 

  • Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Robertson DW. Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol. 2000;57(1):75–81.

    PubMed  CAS  Google Scholar 

  • Foguet M, Hoyer D, Pardo LA, Parekh A, Kluxen FW, Kalkman HO, Lübbert H. Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J. 1992;11(9):3481–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Glusa E, Pertz HH. Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors. Br J Pharmacol. 2000;130(3):692–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Helton LA, Thor KB, Baez M. 5-Hydroxytryptamine2A, 5-hydroxytryptamine2B, and 5-hydroxytryptamine2C receptor mRNA expression in the spinal cord of rat, cat, monkey and human. Neuroreport. 1994;5(18):2617–20.

    Article  PubMed  CAS  Google Scholar 

  • Hendrikx M, Van Dorpe J, Flameng W, Daenen W. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature. J Heart Valve Dis. 1996;5(2):235–7.

    PubMed  CAS  Google Scholar 

  • Hirai T, Tokumo K, Tsuchiya D, Nishio H. Expression of mRNA for 5-HT2 receptors and proteins related to inactivation of 5-HT in mouse osteoblasts. J Pharmacol Sci. 2009;109(2):319–23.

    Article  PubMed  CAS  Google Scholar 

  • Hodge JM, Wang Y, Berk M, Collier FM, Fernandes TJ, Constable MJ, Williams LJ. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol Psychiatry. 2013;74(1):32–9.

    Article  PubMed  CAS  Google Scholar 

  • Holohean AM, Hackman JC. Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones. Br J Pharmacol. 2004;143(3):351–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Horvath J, Fross RD, Kleiner-Fisman G, Lerch R, Stalder H, Liaudat S, Lang AE. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Mov Disord. 2004;19(6):656–62.

    Article  PubMed  Google Scholar 

  • Iizuka N, Oka M, Yamada-Okabe H, Hamada K, Nakayama H, Mori N, Hamamoto Y. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray. Int J Oncol. 2004;24(3):565–74.

    PubMed  CAS  Google Scholar 

  • Iversen L, Gibbons S, Treble R, Setola V, Huang X-P, Roth BL. Neurochemical profiles of some novel psychoactive substances. Eur J Pharmacol. 2013;700(1–3):147–51.

    Article  PubMed  CAS  Google Scholar 

  • Jaffré F, Callebert J, Sarre A, Etienne N, Nebigil CG, Launay JM, Monassier L. Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation. 2004;110:969–74.

    Article  PubMed  CAS  Google Scholar 

  • Jaffre F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S, Maroteaux L. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res. 2009;104(1):113–23.

    Article  PubMed  CAS  Google Scholar 

  • Jerman JC, Brough SJ, Gager T, Wood M, Coldwell MC, Smart D, Middlemiss DN. Pharmacological characterisation of human 5-HT2 receptor subtypes. Eur J Pharmacol. 2001;414(1):23–30.

    Article  PubMed  CAS  Google Scholar 

  • Johnson KW, Nelson DL, Dieckman DK, Wainscott DB, Lucaites VL, Audia JE, Phebus LA. Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. Cephalalgia. 2003;23(2):117–23.

    Article  PubMed  CAS  Google Scholar 

  • Kelly CR, Sharif NA. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line. J Pharmacol Exp Ther. 2006;317(3):1254–61.

    Article  PubMed  CAS  Google Scholar 

  • Kim H, Toyofuku Y, Lynn FC, Chak E, Uchida T, Mizukami H, German MS. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010;16(7):804–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kiss B, Horváth A, Némethy Z, Schmidt E, Laszlovszky I, Bugovics G, Szombathelyi Z. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. J Pharmacol Exp Ther. 2010;333(1):328–40.

    Article  PubMed  CAS  Google Scholar 

  • Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M. Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors. Naunyn Schmiedeberg's Arch Pharmacol. 2004;370(2):114–23.

    Article  CAS  Google Scholar 

  • Kolodziejczak M, Bechade C, Gervasi N, Irinopoulou T, Banas SM, Cordier C, Maroteaux L. Serotonin modulates developmental microglia via 5-HT2B receptors: potential implication during synaptic refinement of retinogeniculate projections. ACS Chem Neurosci. 2015;6(7):1219–30.

    Article  PubMed  CAS  Google Scholar 

  • Königshoff M, Dumitrascu R, Udalov S, Amarie OV, Reiter R, Grimminger F, Eickelberg O. Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention. Thorax. 2010;65(11):949–55.

    Article  PubMed  Google Scholar 

  • Kopparapu PK, Tinzl M, Anagnostaki L, Persson JL, Dizeyi N. Expression and localization of serotonin receptors in human breast cancer. Anticancer Res. 2013;33(2):363–70.

    PubMed  Google Scholar 

  • Krabbe G, Matyash V, Pannasch U, Mamer L, Boddeke HWGM, Kettenmann H. Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity. Brain Behav Immun. 2012;26(3):419–28.

    Article  PubMed  CAS  Google Scholar 

  • Kursar JD, Nelson DL, Wainscott DB, Cohen ML, Baez M. Molecular cloning, functional expression, and pharmacological characterisation of a novel serotonin (5-Hydroxytryptamine2F) from rat stomach fundus. Mol Pharmacol. 1992;42:549–57.

    PubMed  CAS  Google Scholar 

  • Kursar JD, Nelson DL, Wainscott D, Baez M. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor. Mol Pharmacol. 1994;46:227–34.

    PubMed  CAS  Google Scholar 

  • Lampron A, Bourdeau I, Hamet P, Tremblay J, Lacroix A. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing’s syndrome. J Clin Endocrinol Metab. 2006;91(9):3611–8.

    Article  PubMed  CAS  Google Scholar 

  • Launay J-M, Birraux G, Bondoux D, Callebert J, Choi D-S, Loric S, Maroteaux L. Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J Biol Chem. 1996;271:3141–7.

    Article  PubMed  CAS  Google Scholar 

  • Launay JM, Hervé P, Peoc’h K, Tournois C, Callebert J, Nebigil C, Maroteaux L. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med. 2002;8:1129–35.

    Article  PubMed  CAS  Google Scholar 

  • Launay J-M, Hervé P, Callebert J, Mallat Z, Collet C, Doly S, Maroteaux L. Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension. Blood. 2012;119(7):1772–80.

    Article  PubMed  CAS  Google Scholar 

  • Li T, Weng S-G, Leng X-S, Peng J-R, Wei Y-H, Mou D-C, Wang W-X. Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells. Hepatobiliary Pancreat Dis Int. 2006;5(1):96–100.

    PubMed  CAS  Google Scholar 

  • Liang YJ, Lai LP, Wang BW, Juang SJ, Chang CM, Leu JG, Shyu KG. Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes. Cardiovasc Res. 2006;72(2):303–12.

    Article  PubMed  CAS  Google Scholar 

  • Liang C, Chen W, Zhi X, Ma T, Xia X, Liu H, Liang T. Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a. Mol Cancer. 2013;12:14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lin S-Y, Chang W-J, Lin C-S, Huang C-Y, Wang H-F, Sun W-H. Serotonin receptor 5-HT2B mediates serotonin-induced mechanical hyperalgesia. J Neurosci. 2011;31(4):1410–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Liu W, Wacker D, Gati C, Han GW, James D, Wang D, Cherezov V. Serial femtosecond rystallography of G protein-coupled receptors. Science. 2013;342(6165):1521–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Locker M, Bitard J, Collet C, Poliard A, Mutel V, Launay JM, Kellermann O. Stepwise control of osteogenic differentiation by 5-HT2B receptor signaling: nitric oxide production and phospholipase A2 activation. Cell Signal. 2006;18(5):628–39.

    Article  PubMed  CAS  Google Scholar 

  • Loric S, Launay J-M, Colas J-F, Maroteaux L. New mouse 5-HT2-like receptor: expression in brain, heart, and intestine. FEBS L. 1992;312:203–7.

    Article  CAS  Google Scholar 

  • Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Milbrandt J. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 2001;61(15):5692–6.

    PubMed  CAS  Google Scholar 

  • Manivet P, Mouillet-Richard S, Callebert J, Nebigil CG, Maroteaux L, Hosoda S, Launay J-M. PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor. J Biol Chem. 2000;275:9324–31.

    Article  PubMed  CAS  Google Scholar 

  • Martí-Solano M, Sanz F, Pastor M, Selent J. A dynamic view of molecular switch behavior at serotonin receptors: implications for functional selectivity. PLoS One. 2014;9(10):e109312.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, Sugano S. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene. 2003;22(21):3307–18.

    Article  PubMed  CAS  Google Scholar 

  • McCorvy JD, Roth BL. Structure and function of serotonin G protein-coupled receptors. Pharmacol Ther. 2015;150:129–42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • McDevitt RA, Neumaier JF. Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective. J Chem Neuroanat. 2011;41(4):234–46.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Cussac D. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther. 2003;306(3):954–64.

    Article  PubMed  CAS  Google Scholar 

  • Monassier L, Laplante MA, Jaffre F, Bousquet P, Maroteaux L, de Champlain J. Serotonin 5-HT2B receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice. Hypertension. 2008;52:301–7.

    Article  PubMed  CAS  Google Scholar 

  • Nebigil CG, Choi D-S, Dierich A, Hickel P, Le Meur M, Messaddeq N, Maroteaux L. Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci U S A. 2000a;97:9508–13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nebigil CG, Launay J-M, Hickel P, Tournois C, Maroteaux L. 5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: cross talk with tyrosine kinase pathways. Proc Natl Acad Sci U S A. 2000b;97(6):2591–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nebigil CG, Etienne N, Messaddeq N, Maroteaux L. Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B-receptor signaling. FASEB J. 2003;17(10):1373–5.

    Article  PubMed  CAS  Google Scholar 

  • Nelson DL, Lucaites VL, Wainscott DB, RA G. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors. Naunyn Schmiedeberg's Arch Pharmacol. 1999;359(1):1–6.

    Article  CAS  Google Scholar 

  • Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, PA C. Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. Cancer Res. 2008;68(13):5152–8.

    Article  PubMed  CAS  Google Scholar 

  • O’Mahony SM, Bulmer DC, Coelho A-M, Fitzgerald P, Bongiovanni C, Lee K, Cryan JF. 5-HT2B receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction. Neurogastroenterol Motil. 2010;22(5):573–8.

    Article  PubMed  CAS  Google Scholar 

  • Oh CK, Drescher MJ, Hatfield JS, DG D. Selective expression of serotonin receptor transcripts in the mammalian cochlea and its subdivisions. Brain Res Mol Brain Res. 1999;70(1):135–40.

    Article  PubMed  CAS  Google Scholar 

  • Ohashi-Doi K, Himaki D, Nagao K, Kawai M, Gale JD, Furness JB, Kurebayashi Y. A selective, high affinity 5-HT2B receptor antagonist inhibits visceral hypersensitivity in rats. Neurogastroenterol Motil. 2009;22(2):e69–76.

    Article  PubMed  CAS  Google Scholar 

  • Onken MD, Worley LA, Tuscan MD, Harbour JW. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn. 2010;12(4):461–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Osredkar D, Krzan M. Expression of serotonin receptor subtypes in rat brain and astrocyte cell cultures: an age-and tissue-dependent process. Period Biol. 2009;111(1):129–35.

    CAS  Google Scholar 

  • Pai V, Marshall A, Hernandez L, Buckley A, Horseman N. Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival. Breast Cancer Res. 2009;11(6):R81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Papageorgiou A, Denef C. Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors. Endocrinology. 2007;148(9):4509–22.

    Article  PubMed  CAS  Google Scholar 

  • Park K-S, Sin P-J, Lee DH, Cha S-K, Kim M-J, Kim N-H, Kong ID. Switching-on of serotonergic calcium signaling in activated hepatic stellate cells. World J Gastroenterol. 2011;17(2):164–73.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pietri M, Schneider B, Mouillet-Richard S, Ermonval M, Mutel V, Launay J-M, Kellermann O. Reactive oxygen species-dependent TNF-alpha converting enzyme activation trough stimulation of 5-HT2B and alpha1D autoreceptors in neuronal cells. FASEB J. 2005;19:1078–87.

    Article  PubMed  CAS  Google Scholar 

  • Pitychoutis P, Belmer A, Moutkine I, Adrien J, Maroteaux L. Mice lacking the serotonin Htr2B receptor gene present an antipsychotic-sensitive schizophrenic-like phenotype. Neuropsychopharmacology. 2015;40(12):2764–73.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Sheardown MJ. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol. 1999;128(1):13–20.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Al-Mousily F. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats. J Pharmacol Exp Ther. 2010;334(2):364–72.

    Article  PubMed  CAS  Google Scholar 

  • Rickli A, Kopf S, Hoener MC, Liechti ME. Pharmacological profile of novel psychoactive benzofurans. Br J Pharmacol. 2015;172(13):3412–25.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation. 1995;92(4):790–5.

    Article  PubMed  CAS  Google Scholar 

  • Roth BL. Drugs and valvular heart disease. N Engl J Med. 2007;356(1):6–9.

    Article  PubMed  CAS  Google Scholar 

  • Ruddell RG, Oakley F, Hussain Z, Yeung I, Bryan-Lluka LJ, Ramm GA, Mann DA. A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol. 2006;169(3):861–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Russell A, Banes A, Berlin H, Fink GD, Watts SW. 5-Hydroxytryptamine2B receptor function is enhanced in the N(omega)-Nitro-L-arginine hypertensive rat. J Pharmacol Exp Ther. 2002;303(1):179–87.

    Article  PubMed  CAS  Google Scholar 

  • Sanden N, Thorlin T, Blomstrand F, Persson PA, Hansson E. 5-Hydroxytryptamine2B receptors stimulate Ca2+ increases in cultured astrocytes from three different brain regions. Neurochem Int. 2000;36(4–5):427–34.

    Article  PubMed  CAS  Google Scholar 

  • Schmitz B, Ullmer C, Segelcke D, Gwarek M, Zhu X-R, Lübbert H. BF-1--a novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs. Eur J Pharmacol. 2015;751:73–80.

    Article  PubMed  CAS  Google Scholar 

  • Schmuck K, Ullmer C, Engels P, Lübbert H. Cloning and functionnal characterisation of the human 5-HT2B serotonin receptor. FEBS L. 1994;342:85–90.

    Article  CAS  Google Scholar 

  • Schmuck K, Ullmer C, Kalkman H, Probst A, Lübbert H. Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache? Eur J Neurosci. 1996;8:959–67.

    Article  PubMed  CAS  Google Scholar 

  • Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Roth BL. 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol. 2003;63(6):1223–9.

    Article  PubMed  CAS  Google Scholar 

  • Shahid M, Walker GB, Zorn SH, Wong EHF. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharm. 2009;23(1):65–73.

    Article  CAS  Google Scholar 

  • Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Mailman R. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology. 2003;28(8):1400–11.

    Article  PubMed  CAS  Google Scholar 

  • Sharif NA, Senchyna M. Serotonin receptor subtype mRNA expression in human ocular tissues, determined by RT-PCR. Mol Vis. 2006;12:1040–7.

    PubMed  CAS  Google Scholar 

  • Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, Wortsman J. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol. 2003;196(1):144–53.

    Article  PubMed  CAS  Google Scholar 

  • Slominski A, Pisarchik A, Wortsman J. Expression of genes coding melatonin and serotonin receptors in rodent skin. Biochim Biophys Acta. 2004;1680(2):67–70.

    Article  PubMed  CAS  Google Scholar 

  • Soll C, Jang JH, Riener M-O, Moritz W, Wild PJ, Graf R, Clavien P-A. Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology. 2010;51(4):1244–54.

    Article  PubMed  CAS  Google Scholar 

  • Soll C, Riener M-O, Oberkofler CE, Hellerbrand C, Wild PJ, Deoliveira ML, Clavien P-A. Expression of serotonin receptors in human hepatocellular cancer. Clin Cancer Res. 2012;18(21):5902–10.

    Article  PubMed  CAS  Google Scholar 

  • Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun. 2000;14(3):219–24.

    Article  PubMed  CAS  Google Scholar 

  • Su Y-S, Chiu Y-Y, Lin S-Y, Chen C-C, Sun W-H. Serotonin receptor 2B mediates mechanical hyperalgesia by regulating transient receptor potential vanilloid 1. J Mol Neurosci. 2016;59(1):113–25.

    Article  PubMed  CAS  Google Scholar 

  • Svejda B, Kidd M, Giovinazzo F, Eltawil K, Gustafsson BI, Pfragner R, Modlin IM. The 5-HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment. Cancer. 2010;116(12):2902–12.

    Article  PubMed  CAS  Google Scholar 

  • Tadros SF, D’Souza M, Zettel ML, Zhu X, Lynch-Erhardt M, Frisina RD. Serotonin 2B receptor: upregulated with age and hearing loss in mouse auditory system. Neurobiol Aging. 2007;28(7):1112–23.

    Article  PubMed  CAS  Google Scholar 

  • Tournois C, Mutel V, Manivet P, Launay JM, Kellermann O. Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism. J Biol Chem. 1998;273(28):17498–503.

    Article  PubMed  CAS  Google Scholar 

  • Tschentscher F, Husing J, Holter T, Kruse E, Dresen IG, Jockel KH, Zeschnigk M. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res. 2003;63(10):2578–84.

    PubMed  CAS  Google Scholar 

  • Ullmer C, Schmuck K, Kalkman HO, Lübbert H. Expression of serotonin receptor mRNA in blood vessels. FEBS Lett. 1995;370:215–21.

    Article  PubMed  CAS  Google Scholar 

  • Urtikova N, Berson N, Van Steenwinckel J, Doly S, Truchetto J, Maroteaux L, Conrath M. Antinociceptive effect of peripheral serotonin 5-HT(2B) receptor activation on neuropathic pain. Pain. 2012;153(6):1320–31.

    Article  PubMed  CAS  Google Scholar 

  • van Gils W, Lodder EM, Mensink HW, Kiliç E, Naus NC, Brüggenwirth HT, de Klein A. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. Invest Ophthalmol Vis Sci. 2008;49(10):4254–62.

    Article  PubMed  Google Scholar 

  • Vane JR. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957;12(3):344–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wacker D, Wang C, Katritch V, Han GW, Huang XP, Vardy E, Stevens RC. Structural features for functional selectivity at serotonin receptors. Science. 2013;340(6132):615–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wainscott DB, Cohen ML, Schenck KW, Audia JE, Nissen JS, Baez M, Nelson DL. Pharmacological characteristics of the newly cloned rat 5-Hydroxytryptamine 2F receptor. Mol Pharmacol. 1993;43:419–26.

    PubMed  CAS  Google Scholar 

  • Wainscott DB, Lucaites VL, Kursar JD, Baez M, Nelson DL. Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences. J Pharmacol Exp Ther. 1996;276(2):720–7.

    PubMed  CAS  Google Scholar 

  • Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Xu HE. Structural basis for molecular recognition at serotonin receptors. Science. 2013;340(6132):610–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Watts SW, Fink GD. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt- hypertensive rats. Am J Phys. 1999;276(3 Pt 2):H944–52.

    CAS  Google Scholar 

  • Watts SW, Baez M, Webb RC. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate- salt hypertensive rats. J Pharmacol Exp Ther. 1996;277(2):1103–13.

    PubMed  CAS  Google Scholar 

  • Weir EK, Obreztchikova M, Hong Z. Fenfluramine: riddle or Rosetta stone? Eur Respir J. 2008;31(2):232–5.

    Article  PubMed  CAS  Google Scholar 

  • West JD, Carrier EJ, Bloodworth NC, Schroer AK, Chen P, Ryzhova LM, Merryman WD. Serotonin 2B receptor antagonism prevents heritable pulmonary arterial hypertension. PLoS One. 2016;11(2):e0148657.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Westbroek I, van Der Plas A, de Rooij KE, Klein-Nulend J, Nijweide PJ. Expression of serotonin receptors in bone. J Biol Chem. 2001;276:28961–8.

    Article  PubMed  CAS  Google Scholar 

  • Yabanoglu S, Akkiki M, Seguelas MH, Mialet-Perez J, Parini A, Pizzinat N. Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol. 2009;46(4):518–25.

    Article  PubMed  CAS  Google Scholar 

  • Yadav VK, Oury F, Suda N, Liu Z-W, Gao X-B, Confavreux C, Karsenty G. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell. 2009;138(5):976–89.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yan L, Chen X, Talati M, Nunley BW, Gladson S, Blackwell T, Hamid R. Bone marrow-derived cells contribute to pathogenesis of pulmonary arterial hypertension. Am J Resp Crit Care Med. 2016;193(8):898–909.

    Google Scholar 

  • Zhang Y, Yang Y, Chen L, Zhang J. Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma. BMC Med Genet. 2014;15:29.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zopf DA, Neves LAA, Nikula KJ, Huang J, Senese PB, Gralinski MR. C-122, a novel antagonist of serotonin receptor 5-HT(2B), prevents monocrotaline-induced pulmonary arterial hypertension in rats. Eur J Pharmacol. 2011;670(1):195–203.

    Article  PubMed  CAS  Google Scholar 

  • Zsippai A, Szabó DR, Szabó PM, Tömböl Z, Bendes MR, Nagy Z, Igaz P. mRNA and microRNA expression patterns in adrenocortical cancer. Am J Cancer Res. 2011;1(5):618–28.

    PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luc Maroteaux .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Maroteaux, L., Roumier, A., Doly, S., Diaz, S.L., Belmer, A. (2018). HTR2B. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_286

Download citation

Publish with us

Policies and ethics